4.8 Article

Cell-free prototyping enables implementation of optimized reverse β-oxidation pathways in heterotrophic and autotrophic bacteria

Journal

NATURE COMMUNICATIONS
Volume 13, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-30571-6

Keywords

-

Funding

  1. Office of Energy Efficiency and Renewable Energy (EERE) [DE-EE0008343]
  2. U.S. Department of Energy (DOE) Biological and Environmental Research Division (BER), Genomic Science Program (GSP) [DE-SC0018249]
  3. Joint Genome Institute Community Science Program [CSP-503280]
  4. Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]
  5. Swiss National Science Foundation via a SNSF Early Postdoc.Mobility fellowship [P2SKP3_184036]
  6. Ryan Fellowship
  7. International Institute for Nanotechnology at Northwestern University
  8. Zeno Karl Schindler Foundation
  9. Swiss National Science Foundation (SNF) [P2SKP3_184036] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The study demonstrates the use of a high-throughput in vitro prototyping workflow to screen unique pathway combinations and identify enzyme sets for enhanced product selectivity. The combination of reverse beta-oxidation (r-BOX) pathway and Wood-Ljungdahl pathway allows for selective synthesis of C4-C6 acids and alcohols in Escherichia coli and Clostridium autoethanogenum.
An attractive route for carbon-negative synthesis of biochemical products is the reverse beta-oxidation pathway coupled to the Wood-Ljungdahl pathway. Here the authors use a high-throughput in vitro prototyping workflow to screen 762 unique pathway combinations using cell-free extracts tailored for r-BOX to identify enzyme sets for enhanced product selectivity. Carbon-negative synthesis of biochemical products has the potential to mitigate global CO2 emissions. An attractive route to do this is the reverse beta-oxidation (r-BOX) pathway coupled to the Wood-Ljungdahl pathway. Here, we optimize and implement r-BOX for the synthesis of C4-C6 acids and alcohols. With a high-throughput in vitro prototyping workflow, we screen 762 unique pathway combinations using cell-free extracts tailored for r-BOX to identify enzyme sets for enhanced product selectivity. Implementation of these pathways into Escherichia coli generates designer strains for the selective production of butanoic acid (4.9 +/- 0.1 gL(-1)), as well as hexanoic acid (3.06 +/- 0.03 gL(-1)) and 1-hexanol (1.0 +/- 0.1 gL(-1)) at the best performance reported to date in this bacterium. We also generate Clostridium autoethanogenum strains able to produce 1-hexanol from syngas, achieving a titer of 0.26 gL(-1) in a 1.5 L continuous fermentation. Our strategy enables optimization of r-BOX derived products for biomanufacturing and industrial biotechnology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available